Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. Fernández-Lahera, F. García Río, I. Fernández, S. Zudaire, R. Casitas, C. Llontop, R. Galera, C. Villasante, R. Álvarez-Sala (Madrid, Spain). Deregulation of carbohydrate metabolism in patients with sleep apnoea. Eur Respir J 2011; 38: Suppl. 55, 2271

Member's Comments

No comment yet.

Related content which might interest you: Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 The role of hyaluronan metabolism in obstructive sleep apnoea Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020 Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Diabetes and metabolic aspects of OSA Source: Eur Respir Mon 2010; 50: 189-215 Year: 2010 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Disregulation of iron metabolism and atherosclerotic changes in Obstructive sleep apnoea Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea Year: 2021 Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002 The influence on hyperlipemia and abnormal glucose metabolism in obstructive sleep apnea-hypopnea syndrome (OSAHS) Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Ghrelin and impaired glucose tolerance in obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 666s Year: 2005 Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea Source: Eur Respir J 2011; 37: 1418-1423 Year: 2011 Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 The metabolic consequences of obstructive sleep apnoea in children Source: Breathe 2009; 6: 111-114 Year: 2009 Risk of obstructive sleep apnea and impaired glucose metabolism in non-diabetic subjects Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 The puzzle of metabolic effects of obstructive sleep apnoea in children Source: Eur Respir J 2016; 47: 1050-1053 Year: 2016 Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003 Erythrocyte glycolysis in severe obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005 Exercise responses in patients with sleep apnoea Source: Virtual Congress 2020 – Exercise and sleep: from impaired function to new therapeutic strategies Year: 2020 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 APAP impact on metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009